Acute traumatic coagulopathy: Pathophysiology and resuscitation

British Journal of Anaesthesia

Volumn 117, Issue , 2016, Pages iii31-iii43

  Simmons, J W ^a   Powell, M F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

coagulation; physiology; resuscitation; transfusion; trauma

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; FIBRINOGEN; THROMBIN; THROMBOPLASTIN;

ACIDEMIA; ACUTE TRAUMATIC COAGULOPATHY; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CAUSE OF DEATH; CRYOPRECIPITATE; CRYSTALLOID; DISEASE CONTROL; ENDOTHELIAL GLYCOCALYX; ERYTHROCYTE TRANSFUSION; EXSANGUINATION; FIBRINOLYSIS; GLYCOCALYX; HEMODILUTION; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; HYPOTENSION; HYPOTHERMIA; INFUSION; MULTIPLE TRAUMA; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; THROMBOCYTE DYSFUNCTION; WARMING; BLOOD; COMPLICATION; INJURY; PROCEDURES; SHOCK;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HUMANS; RESUSCITATION; SHOCK; WOUNDS AND INJURIES;

EID: 85021451780     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aew328     Document Type: Review

References (116)

1. CDC. 10 Leading Causes of Death By Age Group, United States-2014. 2014. Available from http://www. cdc. gov/in jury/wisqars/leadingcauses. html (accessed 23 May 2016)
2. WHO. World Heath Statistics 2016, Monitoring Health for the SDGs. 2016. Available from http://www. who. int/gho/ publications/world-health-statistics/en/(accessed 23 May 2016)
3. Hoffman M, Monroe DM, 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65
4. Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam 2011; 2011: 367284
5. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006; 32: 11-23
6. Wildgoose P, Kisiel W. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood 1989; 73: 1888-95
7. Allen DH, Tracy PB. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J Biol Chem 1995; 270: 1408-15
8. Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996; 7: 459-64
9. Hultin MB. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets. Blood 1985; 66: 53-8
10. Cadroy Y, Diquelou A, Dupouy D, et al. The thrombomodulin/ protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium. Arterioscler Thromb Vasc Biol 1997; 17: 520-7
11. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett 2005; 579: 3310-6
12. Cohen MJ, Call M, Nelson M, et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012; 255: 379-85
13. Sakamoto T, Ogawa H, Takazoe K, et al. Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin. J Am Coll Cardiol 2003; 42: 1389-94
14. Cohen MJ, Kutcher M, Redick B, et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg 2013; 75: S40-7
15. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-8
16. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock 2009; 32: 659-65
17. Campbell JE, Meledeo MA, Cap AP. Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy. PLoS One 2014; 9: e99181
18. Howard BM, Kornblith LZ, Cheung CK, et al. Inducing acute traumatic coagulopathy in vitro: the effects of activated protein c onhealthyhumanwhole blood. PLoS One 2016; 11: e0150930
19. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, Oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345-59
20. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-906
21. Maegele M, Schochl H, Cohen MJ. An update on the coagulopathy of trauma. Shock 2014; 41 (suppl 1): 21-5
22. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254: 194-200
23. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010; 75: 564-7
24. Liu J, Pedersen LC. Anticoagulant heparan sulfate: structural specificity and biosynthesis. Appl Microbiol Biotechnol 2007; 74: 263-72
25. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012; 73: 60-6
26. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74
27. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21
28. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. Am J Clin Pathol 2011; 136: 364-70
29. Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock 2014; 41: 514-21
30. Moore HB, Moore EE, Gonzalez E, et al. Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock 2015; 43: 39-46
31. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-7
32. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51
33. Kornblith LZ, Kutcher ME, Redick BJ, Calfee CS, Vilardi RF, Cohen MJ. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 2014; 76: 255-63
34. Kutcher ME, Redick BJ, McCreery RC, et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012; 73: 13-9
35. Wohlauer MV, Moore EE, Thomas S, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012; 214: 739-46
36. Moore HB, Moore EE, Chapman MP, et al. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients. J Thromb Haemost 2015; 13: 1878-87
37. Stansbury LG, Hess AS, Thompson K, Kramer B, Scalea TM, Hess JR. The clinical significance of platelet counts in the first 24 hours after severe injury. Transfusion 2013; 53: 783-9
38. Brown LM, Call MS, Margaret Knudson M, et al. A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J Trauma 2011; 71: S337-42
39. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38: 298-304
40. Scharbert G, Kalb ML, Essmeister R, Kozek-Langenecker SA. Mild and moderate hypothermia increases platelet aggregation induced by various agonists: a whole blood in vitro study. Platelets 2010; 21: 44-8
41. Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56: 1221-8
42. Mitrophanov AY, Rosendaal FR, Reifman J. Computational analysis of the effects of reduced temperature on thrombin generation: the contributions of hypothermia to coagulopathy. Anesth Analg 2013; 117: 565-74
43. Martini WZ, Dubick MA, Pusateri AE, Park MS, Ryan KL, Holcomb JB. Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma 2006; 61: 99-106
44. Wang HE, Callaway CW, Peitzman AB, Tisherman SA. Admission hypothermia and outcome after major trauma. Crit Care Med 2005; 33: 1296-301
45. Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990; 160: 515-8
46. Callcut RA, Cotton BA, Muskat P, et al. Defining when to initiate massive transfusion: a validation study of individual massive transfusion triggers in PROMMTT patients. J Trauma Acute Care Surg 2013; 74: 59-65
47. Schochl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265
48. Callcut RA, Johannigman JA, Kadon KS, Hanseman DJ, Robinson BR. All massive transfusion criteria are not created equal: defining the predictive value of individual transfusion triggers to better determine who benefits from blood. J Trauma 2011; 70: 794-801
49. Callcut RA, Cripps MW, Nelson MF, Conroy AS, Robinson BB, Cohen MJ. The massive transfusion score as a decision aid for resuscitation: learning when to turn the massive transfusion protocol on and off. J Trauma Acute Care Surg 2016; 80: 450-6
50. Ogura T, Nakamura Y, Nakano M, et al. Predicting the need for massive transfusion in trauma patients: the Traumatic Bleeding Severity Score. J Trauma Acute Care Surg 2014; 76: 1243-50
51. Pommerening MJ, Goodman MD, Holcomb JB, et al. Clinical gestalt and the prediction of massive transfusion after trauma. Injury 2015; 46: 807-13
52. Maegele M, Lefering R, Wafaisade A, et al. Revalidation and update of the TASH-Score: a scoring system to predict the probability for massive transfusion as a surrogate for lifethreatening haemorrhage after severe injury. Vox Sang 2011; 100: 231-8
53. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma 2009; 66: 346-52
54. Moon TS, Sappenfield J. Anesthetic management and challenges in the pregnant patient. Curr Anesthesiol Rep 2016; 6: 89-94
55. Conti B, Villacin MK, Simmons JW. Trauma anesthesia for traumatic brain injury. Curr Anesthesiol Rep 2016; 6: 95-101
56. Sherren PB, Hussey J, Martin R, Kundishora T, Parker M, Emerson B. Acute burn induced coagulopathy. Burns 2013; 39: 1157-61
57. Siegal DM, Crowther MA. Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J 2013; 34: 489-98
58. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382
59. Cotton BA, Reddy N, Hatch QM, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254: 598-605
60. Moore EE, Burch JM, Franciose RJ, Offner PJ, Biffl WL. Staged physiologic restoration and damage control surgery. World J Surg 1998; 22: 1184-90
61. Brenner M, Bochicchio G, Bochicchio K, et al. Long-term impact of damage control laparotomy: a prospective study. Arch Surg 2011; 146: 395-9
62. Lamb CM, MacGoey P, Navarro AP, Brooks AJ. Damage control surgery in the era of damage control resuscitation. Br J Anaesth 2014; 113: 242-9
63. Tobin JM, Grabinsky A, McCunn M, et al. A checklist for trauma and emergency anesthesia. Anesth Analg 2013; 117: 1178-84
64. Behrens V, Dudaryk R, Nedeff N, Tobin JM, Varon AJ. The ryder cognitive aid checklist for trauma anesthesia. Anesth Analg 2016; 122: 1484-7
65. Short R, Almeida R. Management of analgesia through multiple phases of trauma. Curr Anesthesiol Rep 2016; 6: 6-15
66. Inaba K, Berg R, Barmparas G, et al. Prospective evaluation of ambient operating room temperature on the core temperature of injured patients undergoing emergent surgery. J Trauma Acute Care Surg 2012; 73: 1478-83
67. Tsuei BJ, Kearney PA. Hypothermia in the trauma patient. Injury 2004; 35: 7-15
68. Darocha T, Kosinski S, Jarosz A, Drwila R. Extracorporeal rewarming from accidental hypothermia of patient with suspected trauma. Medicine (Baltimore) 2015; 94: e1086
69. Jarosz A, Kosinski S, Darocha T, Paal P, Gaazkowski R, Hymczak H, et al. The problems and pitfalls of qualification for extracorporeal rewarming in severe accidental hypothermia. J Cardiothorac Vasc Anesth 2016, In Press, http://dx. doi. org/ 10. 1053/j. jvca. 2016. 05. 015 (accessed 10 December 2016)
70. Perlman R, Callum J, Laflamme C, et al. A recommended early goal-directed management guideline for the prevention of hypothermia-related transfusion, morbidity, and mortality in severely injured trauma patients. Crit Care 2016; 20: 107
71. Paul JE, Ling E, Lalonde C, Thabane L. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 2007; 54: 799-810
72. Schreiber MA, Meier EN, Tisherman SA, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg 2015; 78: 687-95
73. Carrick MM, Morrison CA, Tapia NM, et al. Intraoperative hypotensive resuscitation for patients undergoing laparotomy or thoracotomy for trauma: early termination of a randomized prospective clinical trial. J Trauma Acute Care Surg 2016; 80: 886-96
74. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216-22
75. Tobin JM, Dutton RP, Pittet JF, Sharma D. Hypotensive resuscitation in a head-injured multi-trauma patient. J Crit Care 2014; 29: 313 e1-5
76. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100
77. Sperry JL, Minei JP, Frankel HL, et al. Early use of vasopressors after injury: caution before constriction. J Trauma 2008; 64: 9-14
78. Harrois A, Baudry N, Huet O, et al. Norepinephrine decreases fluid requirements and blood loss while preserving intestinal villi microcirculation during fluid resuscitation of uncontrolled hemorrhagic shock in mice. Anesthesiology 2015; 122: 1093-102
79. Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg 2011; 35: 430-9
80. Marx G, Schindler AW, Mosch C, et al. Intravascular volume therapy in adults: guidelines from the association of the scientific medical societies in Germany. Eur J Anaesthesiol 2016; 33: 488-521
81. Hussmann B, Lefering R, Waydhas C, et al. Does increased prehospital replacement volume lead to a poor clinical course and an increasedmortality? Amatched-pair analysis of 1896 patients of the Trauma Registry of the German Society for Trauma Surgerywho were managed by an emergency doctor at the accident site. Injury 2013; 44: 611-7
82. Kasotakis G, Sideris A, Yang Y, et al. Aggressive early crystalloid resuscitation adversely affects outcomes in adult blunt trauma patients. An analysis of the glue grant database. J Trauma Acute Care Surg 2013; 74: 1215-21
83. Skellett S, Mayer A, Durward A, Tibby S, Murdoch I. Chasing the base deficit: hyperchloraemic acidosis following 0. 9% saline fluid resuscitation. Arch Dis Child 2000; 83: 514-6
84. Poole D. Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence. Blood Transfus 2016; 14: 3-7
85. Collaborators C, Roberts I, Shakur H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101
86. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313: 471-82
87. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55
88. Gonzalez E, Moore EE, Moore HB, et al. Goaldirected Hemostatic Resuscitation of Trauma-induced Coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 2016; 263: 1051-9
89. Holcomb JB, Zarzabal LA, Michalek JE, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71: S318-28
90. de Biasi AR, Stansbury LG, Dutton RP, Stein DM, Scalea TM, Hess JR. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME). Transfusion 2011; 51: 1925-32
91. Davenport R, Brohi K. Fibrinogen depletion in trauma: early, easy to estimate and central to trauma-induced coagulopathy. Crit Care 2013; 17: 190
92. Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2016; 125: 46-61
93. Ripolles MJ, Casans FR, Espinosa A, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: a systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiol 2016; 82: 582-98
94. Docherty AB, O'donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. Br Med J 2016; 352: i1351
95. Li J, Sun SL, Tian JH, Yang K, Liu R, Li J. Cell salvage in emergency trauma surgery. Cochrane Database Syst Rev 2015; 1: CD007379
96. Khan S, Davenport R, Raza I, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 2015; 41: 239-47
97. Khan S, Brohi K, Chana M, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 2014; 76: 561-7
98. Dudaryk R, Sheffy N, Hess JR. Changing paradigms in hemostatic resuscitation: timing, extent, economic impact, and the role of factor concentrates. Curr Anesthesiol Rep 2016; 6: 30-5
99. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011; 107: 378-87
100. Ramsey MT, Fabian TC, Shahan CP, et al. A prospective study of platelet function in trauma patients. J Trauma Acute Care Surg 2016; 80: 726-33
101. Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res 2015; 193: 802-6
102. Simmons JW, Pittet JF, Pierce B. Trauma-Induced Coagulopathy. Curr Anesthesiol Rep 2014; 4: 189-99
103. Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost 2015; 41: 35-42
104. Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, et al. Guidelines for postoperative care in gynecologic/ oncology surgery: enhanced recovery after surgery (ERAS(R) Society recommendations-Part II. Gynecol Oncol 2016; 140: 323-332
105. Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a timevarying treatment with competing risks. JAMA Surg 2013; 148: 127-36
106. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73
107. Maegele M, Zinser M, Schlimp C, Schochl H, Fries D. Injectable hemostatic adjuncts in trauma: fibrinogen and the FIinTIC study. J Trauma Acute Care Surg 2015; 78: S76-82
108. Murdock AD, Berseus O, Hervig T, Strandenes G, Lunde TH. Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock 2014; 41 (suppl 1): 62-9
109. Auten JD, Lunceford NL, Horton JL, et al. The safety of early fresh, whole blood transfusion among severely battle injured at US Marine Corps forward surgical care facilities in Afghanistan. J Trauma Acute Care Surg 2015; 79: 790-6
110. Nessen SC, Eastridge BJ, Cronk D, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion 2013; 53: 107S-13S
111. Rahbar E, Cardenas JC, Matijevic N, et al. Trauma, time, and transfusions: a longitudinal analysis of coagulation markers in severely injured trauma patients receiving modified whole blood or component blood products. Shock 2015; 44: 417-25
112. Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock A. Initial safety and feasibility of cold stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg 2016; 81: 21-26
113. Brown JB, Neal MD, Guyette FX, et al. Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: addressing the knowledge gaps. Prehosp Emerg Care 2015; 19: 79-86
114. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings fromtheMATTERs II Study. JAMA Surg 2013; 148: 218-25
115. MooreHB, Moore EE, Liras IN, et al. Acute fibrinolysis shutdown after injury occurs frequently and increasesmortality: amulticenter evaluation of 2, 540 severely injured patients. J Am Coll Surg 2016; 222: 347-55
116. Roberts I, Perel P, Prieto-Merino D, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 2012; 345: e5839